Session One: Assessing Vaccine Program Impact

Note: All session times are shown in Eastern Standard Time (EST), USA & Canada.

Monday, March 26, 2012: 12:00 PM-1:00 PM
Conference Room
Moderator:
Gina Mootrey

12:00 PM
Welcome
Anne Schuchat, MD
     
12:03 PM
Opening Remarks
Gina Mootrey
           
12:05 PM
Early Impact of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) On Invasive Pneumococcal Disease — United States, 2010–11
Chad Cox, MD, MPH, Medical Epidemiologist, Centers for Disease Control and Prevention
        
12:20 PM
Overview of Model and Results of Influenza Vaccine Program Effectiveness Project – Using National Surveillance Data to Estimate the Impact of Influenza Vaccine Programs
Joseph Bresee, MD, Chief, Epidemiology and Prevention Branch, Influenza Division, Centers for Disease Control and Prevention
        
12:35 PM
Rotavirus Vaccine: Update On Safety and Impact
Umesh Parashar, MD, MPH, Medical Officer, Centers for Disease Control and Prevention
        
12:50 PM
Questions and Answers
        
See more of: Submissions
<< Previous Session | Next Session >>